CXCL9 and neoplasm: A recent review reports that the CXCL9/CXCL10/CXCL11/CXCR3 axis is responsible for angiogenesis inhibition, and the activation and migration of immune cells such as cytotoxic lymphocytes and natural killer cells into the tumor microenvironment, to prevent tumor progression in BCa [34].